STUDY OF THE EFFICACY OF NEW FOOD PRODUCTS IN PATIENTS WITH CARDIOVASCULAR DISEASES

Abstract

Background: Cardiovascular diseases (CVDs) remain a leading cause of global mortality and disability. In addition to pharmacological management, there is growing interest in the adjunctive role of natural, nutrient-rich products in the comprehensive prevention and treatment of CVDs. This study investigates the efficacy and tolerability of a novel natural phytocomplex, "Cardio-Control," in patients with established cardiovascular pathology.

Objective: To evaluate the clinical effectiveness of the "Cardio-Control" phytocomplex in improving symptoms and physiological parameters in patients with cardiovascular diseases.

Materials and Methods: A clinical study was conducted involving 60 participants aged 60 and older, divided into a main group (n=30) receiving "Cardio-Control" alongside standard therapy and a control group (n=20) receiving standard therapy alone. The study employed a scoring system to assess efficacy (4-point scale) and tolerability (5-point scale). Clinical symptoms (heart pain, blood pressure, pulse rate) and laboratory parameters were monitored before and after a three-month intervention period.

Results: Administration of the "Cardio-Control" phytocomplex resulted in a statistically significant (p<0.001) reduction in key clinical symptoms. Scores for heart pain decreased from 2.7±0.5 to 0.28±0.05, and blood pressure scores improved from 2.5±0.4 to 0.20±0.04 in the main group. Objective parameters also showed improvement, with systolic blood pressure decreasing from 150.0±14.1 mmHg to 125.0±13.1 mmHg. The product demonstrated high efficacy (average score 3.86±0.7) and very good tolerability (average score 3.85±0.6) with no adverse effects reported.

Conclusion: The natural phytocomplex "Cardio-Control" is an effective and well-tolerated adjunctive therapy for patients with cardiovascular diseases, contributing to the alleviation of clinical symptoms and normalization of hemodynamic parameters. It can be recommended for inclusion in comprehensive treatment and prevention regimens for conditions such as coronary heart disease, hypertension, and chronic heart failure.